Early blood immune molecular alterations in cynomolgus monkeys with a PSEN1 mutation causing familial Alzheimer's disease
Authors:
Open Access
- 7 July 2024
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (8) , 5492-5510
Abstract
INTRODUCTION: More robust non‐human primate models of Alzheimer's disease (AD) will provide new opportunities to better understand the pathogenesis and progression of AD.METHODS: We designed a CRISPR/Cas9 system to achieve precise genomic deletion of exon 9 in cynomolgus monkeys using two guide RNAs targeting the 3′ and 5′ intron sequences of PSEN1 exon 9. We performed biochemical, transcriptome, proteome, and biomarker analyses to characterize the cellular and molecular dysregulations of this non‐human primate model.RESULTS: We observed early changes of AD‐related pathological proteins (cerebrospinal fluid Aβ42 and phosphorylated tau) in PSEN1 mutant (ie, PSEN1‐ΔE9) monkeys. Blood transcriptome and proteome profiling revealed early changes in inflammatory and immune molecules in juvenile PSEN1‐ΔE9 cynomolgus monkeys.DISCUSSION: PSEN1 mutant cynomolgus monkeys recapitulate AD‐related pathological protein changes, and reveal early alterations in blood immune signaling. Thus, this model might mimic AD‐associated pathogenesis and has potential utility for developing early diagnostic and therapeutic interventions.Highlights: A dual‐guide CRISPR/Cas9 system successfully mimics AD PSEN1‐ΔE9 mutation by genomic excision of exon 9. PSEN1 mutant cynomolgus monkey‐derived fibroblasts exhibit disrupted PSEN1 endoproteolysis and increased Aβ secretion. Blood transcriptome and proteome profiling implicate early inflammatory and immune molecular dysregulation in juvenile PSEN1 mutant cynomolgus monkeys. Cerebrospinal fluid from juvenile PSEN1 mutant monkeys recapitulates early changes of AD‐related pathological proteins (increased Aβ42 and phosphorylated tau).Keywords
Funding Information
- National Key Research and Development Program of China (2021YFE0203000, 2018YFA0801404, 2021YFC2500103)
- National Natural Science Foundation of China (32100778, 81961128019, 82071187)
This publication has 79 references indexed in Scilit:
- Early molecular events of autosomal‐dominant Alzheimer's disease in marmosets with PSEN1 mutationsAlzheimer's & Dementia, 2024
- Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom OnsetAnnals of Neurology, 2024
- 2023 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2023
- Microglial Activation and Connectivity in Alzheimer Disease and AgingAnnals of Neurology, 2022
- Large‐scale plasma proteomic profiling identifies a high‐performance biomarker panel for Alzheimer's disease screening and stagingAlzheimer's & Dementia, 2021
- A novel tau‐based rhesus monkey model of Alzheimer's pathogenesisAlzheimer's & Dementia, 2021
- Translational animal models for Alzheimer's disease: An Alzheimer's Association Business Consortium Think TankAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2020
- Current state of research on non‐human primate models of Alzheimer’s diseaseAnimal Models and Experimental Medicine, 2019
- ggplot22016
- Role of ninjurin‐1 in the migration of myeloid cells to central nervous system inflammatory lesionsAnnals of Neurology, 2011